REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Elan Corp. PLC ADS (NY: ELN)
12.47 USD  +0.11 (+0.89%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Elan Corp. PLC ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Wohl & Fruchter LLP and Pomerantz Grossman Hufford Dahlstrom & Gross LLP File Consolidated Class Action Complaint on Behalf of Investors in Elan Corporation, plc Alleging Insider Trading by S.A.C. Cap
May 24, 2013
from Business Wire News Releases
Start Making Profits Now With FB, PSE, AMD and ELN
May 24, 2013
from Marketwired News Releases
Free Research Reports on ELN, JNJ, QSII and SIG Issued by the Paragon Report
May 24, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
May 24, 2013
from PR Newswire
Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021
May 23, 2013
from Business Wire News Releases
Hot Movers on Health & Fitness Sector : ELN, MRK, JNJ, GILD
May 23, 2013
New York, NY -- (SBWIRE) -- 05/23/2013 -- The online Stock Consultant latest screen has found a biotech company that develops drugs for Alzheimer's and Parkinson's diseases Elan Corporation, PLC (ADR)... Read More
from SBWire - Latest Press Releases
Elan Trading Higher Today on Above-Average Volume, Consistent With Trend (ELN)
May 23, 2013
from Comtex SmarTrend® News Briefs
Technical Stock Breakout Alert: Elan Corporation, Plc (ADR) (ELN)
May 23, 2013
Bridgewater, MA -- (SBWIRE) -- 05/23/2013 -- The online StockConsultant latest screen has found a biotech company that developes drugs for Alzheimer's and Parkinson's diseases Elan Corporation, plc... Read More
from SBWire - Latest Press Releases
Alkermes posts fourth quarter gains, changes fiscal year
May 23, 2013
Just weeks after biopharmaceutical company Alkermes plc (Nasdaq: ALKS) released positive preliminary results of a Phase 2 clinical study of its drug to treat major depressive disorder, the Waltham,... Read More
category Waltham , James Frates , Biotech , and 5 more.
from Business Journals
Elan (ELN) Rejects Royalty Pharma's $12.50/Share Bid
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8365432 for the full story. Read More
from StreetInsider.com News Articles
Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Offer
May 23, 2013
from Business Wire News Releases
Echo Pharma Lowers Acceptance Threshold in Elan (ELN) Bid to 50%
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8364207 for the full story. Read More
from StreetInsider.com News Articles
Royalty Pharma Waives Down Acceptance Condition to 50% of Elan Shares, Plus One Share
May 23, 2013
Royalty Pharma announced today that it has committed to waive down the Acceptance Threshold from 90 percent to 50 percent of Maximum Elan Shares Affected plus one Elan Share in accordance with the... Read More
category ELN , Benzinga , Global , and 2 more.
from Latest Articles from Benzinga.com
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
May 23, 2013
from PR Newswire
The Reason It Trades, What's Moving ELN, DELL, GILD and KEY
May 23, 2013
from Marketwired News Releases
13F Filings: Superstar Investor Buys and Sells
May 22, 2013
The quarterly 13F filing season lets us peek into the minds of top investors. Health care stocks were in during the quarter, while techs were out. Read More
from Update Content Feed for Financial Content
Profitable Trading Secrets Revealed in F, GE, PFE and ELN
May 21, 2013
from Marketwired News Releases
Benzinga's M&A Chatter for Monday May 20, 2013
May 20, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday May 20, 2013: Actavis to Acquire Warner Chilcott for $8.5B or $20.08/Share in Stock Deal The Deal:Actavis... Read More
category YHOO , Rumors , Management , and 13 more.
from Latest Articles from Benzinga.com
Market Wrap: Yahoo, Tumblr Make it Official; New CEO at Chesapeake; SAC's Cohen Subpoenaed
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8355679 for the full story. Read More
from StreetInsider.com News Articles
Stock Market Today Reacts to Merger Monday on Wall Street
May 20, 2013
It was a muted start for U.S. equities when the stock market today (Monday) opened. But by mid-day, the bulls were back and benchmarks marched higher. Just before noon, the Dow Jones Industrial Average... Read More
category the dow jones , stock market live news , stock market quotes , and 15 more.
from Money Morning
50-Day SMA Crossers 05/20: (ELN) (ACI) (AAPL) Above; (MRK) (TLAB) (CLSN) Below
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354836 for the full story. Read More
from StreetInsider.com News Articles
Share Dealing : ELN, SIRI, RAD, PPHM
May 20, 2013
New York, NY -- (SBWIRE) -- 05/20/2013 -- Elan Corporation, (NYSE:ELN) is +0.405 - +3.47% from the previous close of $11.67. It traded between $11.75 - 12.21 with total traded volume of 22712728... Read More
from SBWire - Latest Press Releases
Elan Trading Higher Today on Above-Average Volume, Consistent With Trend (ELN)
May 20, 2013
from Comtex SmarTrend® News Briefs
Elan Issues Response to Royalty Pharma Bid, Tells Holders to Take No Action
May 20, 2013
The Board of Elan Corporation, plc (NYSE: ELN ) (Elan) notes today's announcement regarding the revised offer by Echo Pharma Acquisition Limited (“Royalty Pharma”) to acquire Elan's shares under Rule... Read More
category ELN , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com
Elan’s Response to Royalty Pharma Announcement
May 20, 2013
from Business Wire News Releases
Streetinsider.com's Hot Lunchtime Reads 05/20: (AAPL) (MKTO) (ELN) (CAT)
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354322 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Royalty Pharma Confirms Increased $12.50/Share Cash Bid for Elan
May 20, 2013
Echo Pharma Acquisition Limited ("Royalty Pharma") today announced, pursuant to Rule 2.5 of the Irish Takeover Rules (the "Announcement"), a firm intention to increase its offer for Elan Corporation,... Read More
category ELN , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
May 20, 2013
Fully Financed, All-Cash Confirmed Offer is Not Conditional on Due Diligence Read More
from PR Newswire
Royalty Pharma raises Elan (ELN) offer to $12.50/share
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354193 for the full story. Read More
from StreetInsider.com News Articles
Royalty Pharma to Raise Bid for Elan (ELN) - CNBC Faber
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353697 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here